Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 5.92% is 5290% above its 5-year average of 0.11%, near the high end of its 5-year range (0.00%–6.45%).
As of the fiscal period ended Tuesday, June 30, 2026. 70.00% above its 12-month average of 3.48%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.92%.
DEBT TO ASSETS RATIO
5.92%
DEBT TO ASSETS RATIO AVG TTM
3.48%
DEBT TO ASSETS RATIO AVG 3Y
0.00%
DEBT TO ASSETS RATIO AVG 5Y
0.11%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+70.00%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
+5289.56%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+6478.12%
vs the sector median at left
Revelation Biosciences, Inc.
Market Cap
$2.94M
Debt to Assets Ratio
5.92%
TTM Avg
3.48%
3Y Avg
0.00%
5Y Avg
0.11%
Market Cap
$3.07M
Debt to Assets Ratio
0.77%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.14M
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.21M
Debt to Assets Ratio
0.06%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$2.66M
Debt to Assets Ratio
0.13%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$3.28M
Debt to Assets Ratio
0.02%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revelation Biosciences, Inc. (REVB) | $2.94M | 5.92% | 3.48% | 0.00% | 0.11% |
| IceCure Medical Ltd (ICCM)vs › | $2.86M | 0.01% | N/A | N/A | N/A |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.07M | 0.77% | N/A | N/A | N/A |
| BioRestorative Therapies, Inc. (BRTX)vs › | $3.14M | 0.01% | N/A | N/A | N/A |
| iSpecimen Inc. (ISPC)vs › | $2.69M | 0.03% | N/A | N/A | N/A |
| Aethlon Medical, Inc. (AEMD)vs › | $3.21M | 0.06% | N/A | N/A | N/A |
| Universe Pharmaceuticals Inc. (UPC)vs › | $2.66M | 0.13% | N/A | N/A | N/A |
| MBody AI Ltd. (MBAI)vs › | $3.25M | 0.00% | N/A | N/A | N/A |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.28M | 0.02% | N/A | N/A | N/A |
| Nexalin Technology, Inc. (NXL)vs › | $3.30M | 0.00% | N/A | N/A | N/A |
Debt/Assets
5.9%
Debt/Equity
0.07
Current Ratio
6.21
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 5.92% |
| 2026-03-31 | 5.05% |
| 2025-12-31 | 6.45% |
| 2025-09-30 | 0.00% |
| 2025-06-30 | 0.00% |
| 2025-03-31 | 0.00% |
| 2024-12-31 | 0.00% |
| 2024-09-30 | 0.00% |
| 2024-06-30 | 0.00% |
| 2024-03-31 | 0.00% |
| 2023-12-31 | 0.00% |
| 2023-09-30 | 0.00% |
| 2023-06-30 | 0.00% |
| 2023-03-31 | 0.00% |
| 2022-12-31 | 0.00% |
| 2022-09-30 | 0.00% |
| 2022-06-30 | 0.00% |
| 2022-03-31 | 0.00% |
| 2021-12-31 | 0.82% |
| 2021-09-30 | 0.56% |
| 2021-06-30 | 0.59% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 3.57% |
